MedKoo Cat#: 524156 | Name: AL-3152

Description:

WARNING: This product is for research use only, not for human or veterinary use.

AL-3152 is a bio-active chemical.

Chemical Structure

AL-3152
AL-3152
CAS#126048-33-7

Theoretical Analysis

MedKoo Cat#: 524156

Name: AL-3152

CAS#: 126048-33-7

Chemical Formula: C16H10F2N2O3

Exact Mass: 316.0660

Molecular Weight: 316.26

Elemental Analysis: C, 60.76; H, 3.19; F, 12.01; N, 8.86; O, 15.18

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.
Bulk Inquiry
Related CAS #
No Data
Synonym
AL-3152; AL 3152; AL3152;
IUPAC/Chemical Name
Spiro(9H-fluorene-9,4'-imidazolidine)-2',5'-dione, 2,7-difluoro-4-methoxy-
InChi Key
FYDPXVSFSSBHGW-MRXNPFEDSA-N
InChi Code
InChI=1S/C16H10F2N2O3/c1-23-12-6-8(18)5-11-13(12)9-3-2-7(17)4-10(9)16(11)14(21)19-15(22)20-16/h2-6H,1H3,(H2,19,20,21,22)/t16-/m1/s1
SMILES Code
N1[C@@]2(c3cc(ccc3c3c(cc(cc23)F)OC)F)C(=O)NC1=O
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO, not in water
Shelf Life
>2 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
More Info

Preparing Stock Solutions

The following data is based on the product molecular weight 316.26 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
1: Robison WG Jr, Laver NM, Jacot JL, Chandler ML, York BM, Glover JP. Efficacy of treatment after measurable diabeticlike retinopathy in galactose-fed rats. Invest Ophthalmol Vis Sci. 1997 May;38(6):1066-73. PubMed PMID: 9152226. 2: Park YH, Mayer PR, Barker R, DuPriest M, Griffin BW, Williams GW, York BM, Slattery JT. Comparison of the pharmacokinetics and pharmacodynamics of the aldose reductase inhibitors, AL03152 (RS), AL03802 (R), and AL03803 (S). Pharm Res. 1993 Apr;10(4):593-7. PubMed PMID: 8483844. 3: Kiss AD, Haggard K, Veltman JC, Ziegler DM. Oxidation of aldose reductase inhibitors ALO-4114 and ALO-3152 catalyzed by liver microsomes. Drug Metab Dispos. 1992 Nov-Dec;20(6):948-53. PubMed PMID: 1362951. 4: Chien JY, Banfield CR, Brazzell RK, Mayer PR, Slattery JT. Saturable tissue binding and imirestat pharmacokinetics in rats. Pharm Res. 1992 Apr;9(4):469-73. PubMed PMID: 1495891. 5: Reddy VN, Lin LR, Giblin FJ, Lou M, Kador PF, Kinoshita JH. The efficacy of aldose reductase inhibitors on polyol accumulation in human lens and retinal pigment epithelium in tissue culture. J Ocul Pharmacol. 1992 Spring;8(1):43-52. PubMed PMID: 1402294.